Related Experiment Video

Updated: Dec 23, 2025

Construction and Evaluation of a Murine Calvarial Osteolysis Model by Exposure to CoCrMo Particles in Aseptic Loosening
09:46

Construction and Evaluation of a Murine Calvarial Osteolysis Model by Exposure to CoCrMo Particles in Aseptic Loosening

Published on: February 17, 2018

8.8K

Modulated podosome patterning in osteoclasts by fullerenol nanoparticles disturbs the bone resorption for

Kui Chen1, Huan Geng2, Wei Liang2

  • 1Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, 100049, P.R. China. xinggm@ihep.ac.cn and University of Chinese Academy of Sciences, Beijing 100049, P.R. China.

Nanoscale
|April 22, 2020
PubMed

Insights

Fullerenol nanoparticles (fNPs) effectively inhibit osteoclast differentiation and function. In vivo studies show fNPs treat osteoporosis by improving bone structure and mechanical properties, offering a promising therapeutic candidate.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Bone Biology

Background:

  • Osteoclast (OC) overactivation contributes to bone metabolism diseases like osteoporosis (OP).
  • Previous work suggested fullerenol nanoparticles (fNPs) inhibit OC differentiation and function.
  • Systemic in vivo studies on fNPs for bone diseases, particularly OP, were lacking.

Purpose of the Study:

  • To investigate the in vivo therapeutic effects of fNPs on osteoporosis.
  • To evaluate fNPs' ability to suppress osteoclast differentiation and function in disease models.
  • To assess fNPs' potential as a treatment for osteoporosis.

Main Methods:

  • Investigated fNP effects on murine bone marrow monocyte-derived OCs in vitro.
  • Assessed fNPs in a lipopolysaccharide (LPS)-induced bone erosion mouse model.
  • Evaluated fNPs in an ovariectomy-induced osteoporosis rat model.

Main Results:

  • fNPs significantly suppressed OC differentiation and podosome formation in vitro.
  • fNPs inhibited OC overactivation in the LPS-induced bone erosion model.
  • In the osteoporosis model, fNPs improved trabecular bone organization, reduced TRAP-positive cells, enhanced bone parameters, and improved mechanical properties.

Conclusions:

  • fNPs effectively inhibit osteoclast differentiation and function, both in vitro and in vivo.
  • fNPs demonstrate significant therapeutic potential for treating osteoporosis.
  • fNPs show promise as an effective osteoporosis treatment, comparable to diphosphonates.

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

7.0K
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

4.2K

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.7K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.1K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K